Breaking News

  • 7 hours ago

  • Simantini Singh Deo

Mesoblast Reaches Key Milestone in Phase 3 Trial of Rexlemestrocel-L for Chronic Back Pain
Breaking News

More News

MBX Biosciences Appoints Steve Hoerter As CEO And Chairman, Names John Smither CFO

MBX Biosciences Appoints Steve Hoerter As CEO And Chairman, Names John...

Simantini Singh Deo

Ad
Advertisement

Interviews & Opinions

Article

Dr Rajiv Desai on why India's next pharma milestone isn't cheaper generics, it's medicines the world calls Made in India.

FT - Dr Rajiv Desai

Read More

Article
From Pharma R&D to CDSCO Leadership: Dr Santosh Indraksha on Schedule M, COVID-19, AI, and the Future of Indian Pharma

FT - Dr Santosh Indraksha

Magazine Cover
May-June 2026 Edition Issue

The New Kings of Pharma From Molecules to Meaning

Cover Story – Data Nationalism: Who Owns the Patient Genome? and the future of healthcare data ownership.

Pharma News – Global updates on drug approvals, AI partnerships, clinical trials, and industry developments.

In Talks with Leadership – Conversations with Vikram Shukla and Prashant Menon.

Startup Story – Featuring KVault and its approach to secure data protection and digital trust.

Market Insights & Commercial Lens – Trust in pharma, compliance, commercial impact, and modern marketing challenges.

Ad
Advertisement
Ad

Pharma Shorts